World's Best Scientists 2026 revealed!
Jukka Partanen

Jukka Partanen

D-Index & Metrics

Immunology

D-Index
66
Citations
14249
World Ranking
2776
National Ranking
21

Jukka Partanen publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Jukka Partanen sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 254 publications — 52nd percentile

52% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Jukka Partanen D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Jukka Partanen sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 66 D-Index — 45th percentile

45% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Jukka Partanen is affiliated with the Finnish Red Cross in Finland. Their research spans several fields, primarily focusing on Medicine, Biochemistry, Genetics and Molecular Biology, and Immunology and Microbiology.

Their main subfields of study include Immunology, Genetics, Hematology, Molecular Biology, and Public Health, Environmental and Occupational Health.

The topics covered in their work encompass T-cell and B-cell Immunology, Immune Cell Function and Interaction, Renal Transplantation Outcomes and Treatments, Genetic Associations and Epidemiology, Blood Groups and Transfusion, Sperm and Testicular Function, and Reproductive Biology and Fertility.

Jukka Partanen has contributed to numerous scientific publications, including papers with significant citations. Recent notable papers include:

  • Proteomic aging clock predicts mortality and risk of common age-related diseases in diverse populations (2024) published in Nature Medicine
  • Inherited myeloproliferative neoplasm risk affects haematopoietic stem cells (2020) published in Nature
  • How Communicating Polygenic and Clinical Risk for Atherosclerotic Cardiovascular Disease Impacts Health Behavior: an Observational Follow-up Study (2022) published in Circulation Genomic and Precision Medicine
  • Genetic Risk Factors Associated With Preeclampsia and Hypertensive Disorders of Pregnancy (2023) published in JAMA Cardiology
  • Increasing accuracy of HLA imputation by a population-specific reference panel in a FinnGen biobank cohort (2020) published in NAR Genomics and Bioinformatics

Their frequent co-authors include Jarmo Ritari, Kati Hyvärinen, Satu Koskela, Aarno Palotie, and Heiko Runz.

Jukka Partanen's work is regularly published in several scientific venues, among which are bioRxiv (Cold Spring Harbor Laboratory), Frontiers in Immunology, Human Immunology, Communications Biology, and Heredity.

Best Publications

  • Hla types in celiac disease patients not carrying the DQA1*05-DQB1*02 (DQ2) heterodimer: results from the european genetics cluster on celiac disease

    Kati Karell;Andrew S Louka;Simon J Moodie;Henry Ascher

  • Celiac disease risk in the USA: high prevalence of antiendomysium antibodies in healthy blood donors.

    T Not;K Horvath;I D Hill;J Partanen

  • Celiac disease in patients with severe liver disease: Gluten-free diet may reverse hepatic failure

    Katri Kaukinen;Leena Halme;Pekka Collin;Martti Färkkilä

  • HLA-DQ typing in the diagnosis of celiac disease.

    Katri Kaukinen;Jukka Partanen;Jukka Partanen;Markku Mäki;Markku Mäki;Pekka Collin;Pekka Collin

  • Secretor genotype (FUT2 gene) is strongly associated with the composition of Bifidobacteria in the human intestine.

    Pirjo Wacklin;Harri Mäkivuokko;Noora Alakulppi;Janne Nikkilä

  • Endomysial antibody‐negative coeliac disease: clinical characteristics and intestinal autoantibody deposits

    Teea T Salmi;Pekka Collin;Ilma R Korponay-Szabo;Kaija Laurila

  • Elevation of IgG antibodies against tissue transglutaminase as a diagnostic tool for coeliac disease in selective IgA deficiency

    Ilma Rita Korponay-Szabó;I. Dahlbom;K. Laurila;S. Koskinen

  • Genetic susceptibility to severe course of nephropathia epidemica caused by Puumala hantavirus

    Jukka Mustonen;Jukka Mustonen;Jukka Mustonen;Jukka Partanen;Jukka Partanen;Jukka Partanen;Mari Kanerva;Mari Kanerva;Mari Kanerva;Kari Pietilä;Kari Pietilä;Kari Pietilä

  • The duodenal microbiota composition of adult celiac disease patients is associated with the clinical manifestation of the disease.

    Pirjo Wacklin;Katri Kaukinen;Elina Tuovinen;Pekka Collin

  • AIRE Mutations and Human Leukocyte Antigen Genotypes as Determinants of the Autoimmune Polyendocrinopathy-Candidiasis-Ectodermal Dystrophy Phenotype

    Maria Halonen;Petra Eskelin;Anne-Grethe Myhre;Jaakko Perheentupa

  • Celiac disease and markers of celiac disease latency in patients with primary Sjögren's syndrome

    Sari Iltanen;Pekka Collin;Markku Korpela;Kati Holm

  • Immunoglobulin A autoantibodies against transglutaminase 2 in the small intestinal mucosa predict forthcoming coeliac disease

    T. T. Salmi;P. Collin;O. Jarvinen;K. Haimila

  • Population-Wide Evaluation of Disease Manifestation in Relation to Molecular Genotype in Steroid 21-Hydroxylase (CYP21) Deficiency: Good Correlation in a Well Defined Population

    Jarmo Jääskeläinen;Antti Levo;Raimo Voutilainen;Jukka Partanen

  • HLA-DQ2-negative celiac disease in Finland and Spain.

    Anne Polvi;Eduardo Arranz;Miguel Fernandez-Arquero;Pekka Collin

  • Puumala hantavirus genome in patients with nephropathia epidemica: correlation of PCR positivity with HLA haplotype and link to viral sequences in local rodents.

    A. Plyusnin;J. Hörling;M. Kanerva;J. Mustonen

  • Antibodies to glutamic acid decarboxylase and insulin-dependent diabetes in patients with autoimmune polyendocrine syndrome type I.

    Tiinamaija Tuomi;Petra Björses;Alberto Falorni;Jukka Partanen

  • Intolerance to Cereals Is Not Specific for Coeliac Disease

    K Kaukinen;K Turjanmaa;M Mäki;J Partanen

  • GLOBAL GENE EXPRESSION PROFILE OF HUMAN CORD BLOOD-DERIVED CD133+ CELLS

    Taina Jaatinen;Heidi Hemmoranta;Sampsa Hautaniemi;Jari Niemi

  • Villous tip intraepithelial lymphocytes as markers of early-stage coeliac disease.

    T. T. Järvinen;P. Collin;M. Rasmussen;S. Kyrönpalo

  • Human Leukocyte Antigen–B8-DR3 Is a More Important Risk Factor for Severe Puumala Hantavirus Infection than the Tumor Necrosis Factor–α(−308) G/A Polymorphism

    Satu Mäkelä;Jukka Mustonen;Ilpo Ala-Houhala;Mikko Hurme

Frequent Co-Authors

Markku Mäki
Markku Mäki Tampere University
Pekka Collin
Pekka Collin Tampere University
Katri Kaukinen
Katri Kaukinen Tampere University
Sari Juutinen
Sari Juutinen University of Helsinki
Heini Huhtala
Heini Huhtala Tampere University
Antti Vaheri
Antti Vaheri University of Helsinki
Tomi Pastinen
Tomi Pastinen Children's Mercy Hospital
Olli Vapalahti
Olli Vapalahti University of Helsinki
Mikko Hurme
Mikko Hurme Tampere University
Aarno Palotie
Aarno Palotie University of Helsinki

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in Immunology, exploring related healthcare fields like nursing can broaden career opportunities. Many students pursue specialized tracks such as psychiatric nursing. If cost is a concern, researching cheap psych np programs can help find affordable options without sacrificing quality.

Advanced nursing roles, including Doctor of Nursing Practice (DNP) degrees, offer strong earning potential. To understand compensation variations, it’s useful to review data on how much do dnp nurses make across different states. This insight aids in strategic career planning.

Nurses aiming to specialize further may consider acnp programs, which focus on acute care and critical patient management. This pathway provides advanced skills applicable in various healthcare settings, complementing the immunology background.

Additionally, for those seeking a faster route into practice, exploring the accelerated nurse practitioner program options can make a difference. These programs expedite training while maintaining rigorous standards, helping students enter the workforce more quickly.

Best Scientists Citing Jukka Partanen

Trending Scientists

Recently Published Articles